Edesa Biotech, Inc. (EDSA) financial statements (2021 and earlier)

Company profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
6/30/2019
Q2
3/31/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6767468
Cash and cash equivalents6767468
Short-term investments    0  
Receivables0000000
Inventory, net of allowances, customer advances and progress billings     00
Inventory     00
Prepaid expense1 10000
Deferred costs    0  
Other undisclosed current assets 1     
Total current assets:8867578
Noncurrent Assets
Operating lease, right-of-use asset00000  
Property, plant and equipment0000001
Intangible assets, net (including goodwill)223    
Intangible assets, net (excluding goodwill)223    
Deposits noncurrent assets      0
Other noncurrent assets     0 
Total noncurrent assets:3330001
TOTAL ASSETS:101198579
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1111111
Other undisclosed accounts payable and accrued liabilities1111111
Debt 0  0  
Other undisclosed current liabilities0 00  0
Total current liabilities:1211111
Noncurrent Liabilities
Long-term debt and lease obligation00000  
Operating lease, liability00000  
Liabilities, other than long-term debt000    
Accounts payable and accrued liabilities000    
Other undisclosed noncurrent liabilities   (0)   
Total noncurrent liabilities:00000  
Total liabilities:1211111
Stockholders' equity
Stockholders' equity attributable to parent, including:8757468
Common stock22191515121257
Common stock, value, subscriptions    0  
Additional paid in capital222200 
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0) 
Accumulated deficit(16)(13)(11)(9)(8)(6)(53)
Other undisclosed stockholders' equity attributable to parent      5
Other undisclosed stockholders' equity122    
Total stockholders' equity:9987468
TOTAL LIABILITIES AND EQUITY:101198579

Income statement (P&L) ($ in millions)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
6/30/2019
Q2
3/31/2019
Q2
Revenues 000000
Cost of revenue (0)(0)(0)(0) (0)
Cost of goods and services sold      (0)
Gross profit: (0)00000
Operating expenses(3)(2)(2)(2)(1)(1)(2)
Other undisclosed operating income 0000 0
Operating loss:(3)(2)(2)(2)(1)(1)(2)
Nonoperating income (expense)(0)(0)00000
Investment income, nonoperating0 00000
Foreign currency transaction gain (loss), before tax(0) (0)0(0)00
Loss from continuing operations before income taxes:(3)(2)(2)(1)(1)(1)(2)
Income tax expense    (0)  
Loss before gain (loss) on sale of properties:(3)(2)(2)(1)(1)(1)(2)
Other undisclosed net income    0  
Net loss:(3)(2)(2)(1)(1)(1)(2)
Other undisclosed net loss attributable to parent    (0)  
Net loss available to common stockholders, diluted:(3)(2)(2)(1)(1)(1)(2)

Comprehensive Income ($ in millions)

12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
3/31/2020
Q2
12/31/2019
Q1
6/30/2019
Q2
3/31/2019
Q2
Net loss:(3)(2)(2)(1)(1)(1)(2)
Comprehensive loss:(3)(2)(2)(1)(1)(1)(2)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(0) 0 
Comprehensive loss, net of tax, attributable to parent:(3)(2)(2)(2)(1)(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: